nodes	percent_of_prediction	percent_of_DWPC	metapath
Haloperidol—CYP1A1—Omeprazole—Barrett's esophagus	0.159	0.22	CbGbCtD
Haloperidol—CYP2C19—Esomeprazole—Barrett's esophagus	0.131	0.181	CbGbCtD
Haloperidol—CYP2C19—Omeprazole—Barrett's esophagus	0.077	0.107	CbGbCtD
Haloperidol—CYP1A2—Omeprazole—Barrett's esophagus	0.0711	0.0983	CbGbCtD
Haloperidol—CYP2C9—Omeprazole—Barrett's esophagus	0.0641	0.0886	CbGbCtD
Haloperidol—CYP3A4—Esomeprazole—Barrett's esophagus	0.0632	0.0874	CbGbCtD
Haloperidol—ABCB1—Omeprazole—Barrett's esophagus	0.0622	0.086	CbGbCtD
Haloperidol—CYP2D6—Omeprazole—Barrett's esophagus	0.0586	0.081	CbGbCtD
Haloperidol—CYP3A4—Omeprazole—Barrett's esophagus	0.0372	0.0515	CbGbCtD
Haloperidol—Leukocytoclastic vasculitis—Omeprazole—Barrett's esophagus	0.00497	0.0251	CcSEcCtD
Haloperidol—Leukocytoclastic vasculitis—Esomeprazole—Barrett's esophagus	0.00497	0.0251	CcSEcCtD
Haloperidol—Laryngeal oedema—Omeprazole—Barrett's esophagus	0.0038	0.0192	CcSEcCtD
Haloperidol—Laryngeal oedema—Esomeprazole—Barrett's esophagus	0.0038	0.0192	CcSEcCtD
Haloperidol—Menstrual disorder—Esomeprazole—Barrett's esophagus	0.00358	0.018	CcSEcCtD
Haloperidol—Menstrual disorder—Omeprazole—Barrett's esophagus	0.00358	0.018	CcSEcCtD
Haloperidol—Dysmenorrhoea—Esomeprazole—Barrett's esophagus	0.00268	0.0135	CcSEcCtD
Haloperidol—Dysmenorrhoea—Omeprazole—Barrett's esophagus	0.00268	0.0135	CcSEcCtD
Haloperidol—Leukocytosis—Omeprazole—Barrett's esophagus	0.0026	0.0131	CcSEcCtD
Haloperidol—Leukocytosis—Esomeprazole—Barrett's esophagus	0.0026	0.0131	CcSEcCtD
Haloperidol—Injection site reaction—Esomeprazole—Barrett's esophagus	0.00242	0.0122	CcSEcCtD
Haloperidol—Injection site reaction—Omeprazole—Barrett's esophagus	0.00242	0.0122	CcSEcCtD
Haloperidol—Gynaecomastia—Omeprazole—Barrett's esophagus	0.00218	0.011	CcSEcCtD
Haloperidol—Gynaecomastia—Esomeprazole—Barrett's esophagus	0.00218	0.011	CcSEcCtD
Haloperidol—Hypertonia—Omeprazole—Barrett's esophagus	0.00214	0.0108	CcSEcCtD
Haloperidol—Hypertonia—Esomeprazole—Barrett's esophagus	0.00214	0.0108	CcSEcCtD
Haloperidol—Hepatic function abnormal—Omeprazole—Barrett's esophagus	0.00203	0.0102	CcSEcCtD
Haloperidol—Hepatic function abnormal—Esomeprazole—Barrett's esophagus	0.00203	0.0102	CcSEcCtD
Haloperidol—Photosensitivity—Omeprazole—Barrett's esophagus	0.00202	0.0102	CcSEcCtD
Haloperidol—Photosensitivity—Esomeprazole—Barrett's esophagus	0.00202	0.0102	CcSEcCtD
Haloperidol—Visual disturbance—Omeprazole—Barrett's esophagus	0.00187	0.00942	CcSEcCtD
Haloperidol—Visual disturbance—Esomeprazole—Barrett's esophagus	0.00187	0.00942	CcSEcCtD
Haloperidol—Hypoglycaemia—Omeprazole—Barrett's esophagus	0.00181	0.00915	CcSEcCtD
Haloperidol—Hypoglycaemia—Esomeprazole—Barrett's esophagus	0.00181	0.00915	CcSEcCtD
Haloperidol—Hyponatraemia—Omeprazole—Barrett's esophagus	0.00178	0.00896	CcSEcCtD
Haloperidol—Hyponatraemia—Esomeprazole—Barrett's esophagus	0.00178	0.00896	CcSEcCtD
Haloperidol—Face oedema—Esomeprazole—Barrett's esophagus	0.00171	0.00862	CcSEcCtD
Haloperidol—Face oedema—Omeprazole—Barrett's esophagus	0.00171	0.00862	CcSEcCtD
Haloperidol—Breast disorder—Omeprazole—Barrett's esophagus	0.0016	0.00807	CcSEcCtD
Haloperidol—Breast disorder—Esomeprazole—Barrett's esophagus	0.0016	0.00807	CcSEcCtD
Haloperidol—Dysphagia—Esomeprazole—Barrett's esophagus	0.00153	0.00772	CcSEcCtD
Haloperidol—Dysphagia—Omeprazole—Barrett's esophagus	0.00153	0.00772	CcSEcCtD
Haloperidol—Bronchospasm—Esomeprazole—Barrett's esophagus	0.00151	0.00759	CcSEcCtD
Haloperidol—Bronchospasm—Omeprazole—Barrett's esophagus	0.00151	0.00759	CcSEcCtD
Haloperidol—Sweating increased—Omeprazole—Barrett's esophagus	0.00149	0.00752	CcSEcCtD
Haloperidol—Sweating increased—Esomeprazole—Barrett's esophagus	0.00149	0.00752	CcSEcCtD
Haloperidol—Pancytopenia—Omeprazole—Barrett's esophagus	0.00145	0.00733	CcSEcCtD
Haloperidol—Pancytopenia—Esomeprazole—Barrett's esophagus	0.00145	0.00733	CcSEcCtD
Haloperidol—Neutropenia—Omeprazole—Barrett's esophagus	0.00143	0.00722	CcSEcCtD
Haloperidol—Neutropenia—Esomeprazole—Barrett's esophagus	0.00143	0.00722	CcSEcCtD
Haloperidol—Erectile dysfunction—Omeprazole—Barrett's esophagus	0.00141	0.00711	CcSEcCtD
Haloperidol—Erectile dysfunction—Esomeprazole—Barrett's esophagus	0.00141	0.00711	CcSEcCtD
Haloperidol—Photosensitivity reaction—Omeprazole—Barrett's esophagus	0.0014	0.00704	CcSEcCtD
Haloperidol—Photosensitivity reaction—Esomeprazole—Barrett's esophagus	0.0014	0.00704	CcSEcCtD
Haloperidol—Weight increased—Esomeprazole—Barrett's esophagus	0.00139	0.00702	CcSEcCtD
Haloperidol—Weight increased—Omeprazole—Barrett's esophagus	0.00139	0.00702	CcSEcCtD
Haloperidol—Weight decreased—Omeprazole—Barrett's esophagus	0.00138	0.00698	CcSEcCtD
Haloperidol—Weight decreased—Esomeprazole—Barrett's esophagus	0.00138	0.00698	CcSEcCtD
Haloperidol—Depression—Esomeprazole—Barrett's esophagus	0.00136	0.00686	CcSEcCtD
Haloperidol—Depression—Omeprazole—Barrett's esophagus	0.00136	0.00686	CcSEcCtD
Haloperidol—Jaundice—Esomeprazole—Barrett's esophagus	0.00133	0.00671	CcSEcCtD
Haloperidol—Jaundice—Omeprazole—Barrett's esophagus	0.00133	0.00671	CcSEcCtD
Haloperidol—Hepatobiliary disease—Omeprazole—Barrett's esophagus	0.00129	0.00651	CcSEcCtD
Haloperidol—Hepatobiliary disease—Esomeprazole—Barrett's esophagus	0.00129	0.00651	CcSEcCtD
Haloperidol—Agranulocytosis—Esomeprazole—Barrett's esophagus	0.00127	0.00642	CcSEcCtD
Haloperidol—Agranulocytosis—Omeprazole—Barrett's esophagus	0.00127	0.00642	CcSEcCtD
Haloperidol—Hepatitis—Esomeprazole—Barrett's esophagus	0.00122	0.00618	CcSEcCtD
Haloperidol—Hepatitis—Omeprazole—Barrett's esophagus	0.00122	0.00618	CcSEcCtD
Haloperidol—Hallucination—Esomeprazole—Barrett's esophagus	0.00122	0.00615	CcSEcCtD
Haloperidol—Hallucination—Omeprazole—Barrett's esophagus	0.00122	0.00615	CcSEcCtD
Haloperidol—Urinary tract disorder—Omeprazole—Barrett's esophagus	0.00121	0.0061	CcSEcCtD
Haloperidol—Urinary tract disorder—Esomeprazole—Barrett's esophagus	0.00121	0.0061	CcSEcCtD
Haloperidol—Connective tissue disorder—Omeprazole—Barrett's esophagus	0.0012	0.00607	CcSEcCtD
Haloperidol—Connective tissue disorder—Esomeprazole—Barrett's esophagus	0.0012	0.00607	CcSEcCtD
Haloperidol—Urethral disorder—Omeprazole—Barrett's esophagus	0.0012	0.00605	CcSEcCtD
Haloperidol—Urethral disorder—Esomeprazole—Barrett's esophagus	0.0012	0.00605	CcSEcCtD
Haloperidol—Visual impairment—Esomeprazole—Barrett's esophagus	0.00118	0.00595	CcSEcCtD
Haloperidol—Visual impairment—Omeprazole—Barrett's esophagus	0.00118	0.00595	CcSEcCtD
Haloperidol—Eye disorder—Esomeprazole—Barrett's esophagus	0.00114	0.00577	CcSEcCtD
Haloperidol—Eye disorder—Omeprazole—Barrett's esophagus	0.00114	0.00577	CcSEcCtD
Haloperidol—Immune system disorder—Esomeprazole—Barrett's esophagus	0.00111	0.00558	CcSEcCtD
Haloperidol—Immune system disorder—Omeprazole—Barrett's esophagus	0.00111	0.00558	CcSEcCtD
Haloperidol—Mediastinal disorder—Esomeprazole—Barrett's esophagus	0.0011	0.00557	CcSEcCtD
Haloperidol—Mediastinal disorder—Omeprazole—Barrett's esophagus	0.0011	0.00557	CcSEcCtD
Haloperidol—Alopecia—Esomeprazole—Barrett's esophagus	0.00108	0.00546	CcSEcCtD
Haloperidol—Alopecia—Omeprazole—Barrett's esophagus	0.00108	0.00546	CcSEcCtD
Haloperidol—Mental disorder—Omeprazole—Barrett's esophagus	0.00107	0.00541	CcSEcCtD
Haloperidol—Mental disorder—Esomeprazole—Barrett's esophagus	0.00107	0.00541	CcSEcCtD
Haloperidol—Malnutrition—Omeprazole—Barrett's esophagus	0.00107	0.00538	CcSEcCtD
Haloperidol—Malnutrition—Esomeprazole—Barrett's esophagus	0.00107	0.00538	CcSEcCtD
Haloperidol—Muscle spasms—Omeprazole—Barrett's esophagus	0.00103	0.00517	CcSEcCtD
Haloperidol—Muscle spasms—Esomeprazole—Barrett's esophagus	0.00103	0.00517	CcSEcCtD
Haloperidol—Vision blurred—Esomeprazole—Barrett's esophagus	0.001	0.00507	CcSEcCtD
Haloperidol—Vision blurred—Omeprazole—Barrett's esophagus	0.001	0.00507	CcSEcCtD
Haloperidol—Tremor—Esomeprazole—Barrett's esophagus	0.000999	0.00504	CcSEcCtD
Haloperidol—Tremor—Omeprazole—Barrett's esophagus	0.000999	0.00504	CcSEcCtD
Haloperidol—Anaemia—Omeprazole—Barrett's esophagus	0.000986	0.00497	CcSEcCtD
Haloperidol—Anaemia—Esomeprazole—Barrett's esophagus	0.000986	0.00497	CcSEcCtD
Haloperidol—Agitation—Esomeprazole—Barrett's esophagus	0.00098	0.00494	CcSEcCtD
Haloperidol—Agitation—Omeprazole—Barrett's esophagus	0.00098	0.00494	CcSEcCtD
Haloperidol—Vertigo—Omeprazole—Barrett's esophagus	0.000958	0.00483	CcSEcCtD
Haloperidol—Vertigo—Esomeprazole—Barrett's esophagus	0.000958	0.00483	CcSEcCtD
Haloperidol—Leukopenia—Esomeprazole—Barrett's esophagus	0.000954	0.00481	CcSEcCtD
Haloperidol—Leukopenia—Omeprazole—Barrett's esophagus	0.000954	0.00481	CcSEcCtD
Haloperidol—Hypertension—Omeprazole—Barrett's esophagus	0.000921	0.00464	CcSEcCtD
Haloperidol—Hypertension—Esomeprazole—Barrett's esophagus	0.000921	0.00464	CcSEcCtD
Haloperidol—Anxiety—Esomeprazole—Barrett's esophagus	0.000905	0.00456	CcSEcCtD
Haloperidol—Anxiety—Omeprazole—Barrett's esophagus	0.000905	0.00456	CcSEcCtD
Haloperidol—Unspecified disorder of skin and subcutaneous tissue—Omeprazole—Barrett's esophagus	0.000902	0.00455	CcSEcCtD
Haloperidol—Unspecified disorder of skin and subcutaneous tissue—Esomeprazole—Barrett's esophagus	0.000902	0.00455	CcSEcCtD
Haloperidol—Dry mouth—Omeprazole—Barrett's esophagus	0.000888	0.00448	CcSEcCtD
Haloperidol—Dry mouth—Esomeprazole—Barrett's esophagus	0.000888	0.00448	CcSEcCtD
Haloperidol—Confusional state—Omeprazole—Barrett's esophagus	0.000877	0.00442	CcSEcCtD
Haloperidol—Confusional state—Esomeprazole—Barrett's esophagus	0.000877	0.00442	CcSEcCtD
Haloperidol—Anaphylactic shock—Esomeprazole—Barrett's esophagus	0.00087	0.00439	CcSEcCtD
Haloperidol—Anaphylactic shock—Omeprazole—Barrett's esophagus	0.00087	0.00439	CcSEcCtD
Haloperidol—Nervous system disorder—Esomeprazole—Barrett's esophagus	0.000853	0.0043	CcSEcCtD
Haloperidol—Nervous system disorder—Omeprazole—Barrett's esophagus	0.000853	0.0043	CcSEcCtD
Haloperidol—Thrombocytopenia—Omeprazole—Barrett's esophagus	0.000852	0.0043	CcSEcCtD
Haloperidol—Thrombocytopenia—Esomeprazole—Barrett's esophagus	0.000852	0.0043	CcSEcCtD
Haloperidol—Tachycardia—Esomeprazole—Barrett's esophagus	0.000849	0.00428	CcSEcCtD
Haloperidol—Tachycardia—Omeprazole—Barrett's esophagus	0.000849	0.00428	CcSEcCtD
Haloperidol—Skin disorder—Omeprazole—Barrett's esophagus	0.000845	0.00426	CcSEcCtD
Haloperidol—Skin disorder—Esomeprazole—Barrett's esophagus	0.000845	0.00426	CcSEcCtD
Haloperidol—Hyperhidrosis—Esomeprazole—Barrett's esophagus	0.000841	0.00424	CcSEcCtD
Haloperidol—Hyperhidrosis—Omeprazole—Barrett's esophagus	0.000841	0.00424	CcSEcCtD
Haloperidol—Anorexia—Omeprazole—Barrett's esophagus	0.00083	0.00418	CcSEcCtD
Haloperidol—Anorexia—Esomeprazole—Barrett's esophagus	0.00083	0.00418	CcSEcCtD
Haloperidol—Insomnia—Esomeprazole—Barrett's esophagus	0.000787	0.00397	CcSEcCtD
Haloperidol—Insomnia—Omeprazole—Barrett's esophagus	0.000787	0.00397	CcSEcCtD
Haloperidol—Dyspnoea—Omeprazole—Barrett's esophagus	0.000776	0.00391	CcSEcCtD
Haloperidol—Dyspnoea—Esomeprazole—Barrett's esophagus	0.000776	0.00391	CcSEcCtD
Haloperidol—Somnolence—Omeprazole—Barrett's esophagus	0.000774	0.0039	CcSEcCtD
Haloperidol—Somnolence—Esomeprazole—Barrett's esophagus	0.000774	0.0039	CcSEcCtD
Haloperidol—Dyspepsia—Esomeprazole—Barrett's esophagus	0.000766	0.00386	CcSEcCtD
Haloperidol—Dyspepsia—Omeprazole—Barrett's esophagus	0.000766	0.00386	CcSEcCtD
Haloperidol—Decreased appetite—Esomeprazole—Barrett's esophagus	0.000756	0.00381	CcSEcCtD
Haloperidol—Decreased appetite—Omeprazole—Barrett's esophagus	0.000756	0.00381	CcSEcCtD
Haloperidol—Gastrointestinal disorder—Omeprazole—Barrett's esophagus	0.000751	0.00379	CcSEcCtD
Haloperidol—Gastrointestinal disorder—Esomeprazole—Barrett's esophagus	0.000751	0.00379	CcSEcCtD
Haloperidol—Constipation—Esomeprazole—Barrett's esophagus	0.000744	0.00375	CcSEcCtD
Haloperidol—Constipation—Omeprazole—Barrett's esophagus	0.000744	0.00375	CcSEcCtD
Haloperidol—Feeling abnormal—Esomeprazole—Barrett's esophagus	0.000717	0.00362	CcSEcCtD
Haloperidol—Feeling abnormal—Omeprazole—Barrett's esophagus	0.000717	0.00362	CcSEcCtD
Haloperidol—Urticaria—Esomeprazole—Barrett's esophagus	0.000691	0.00349	CcSEcCtD
Haloperidol—Urticaria—Omeprazole—Barrett's esophagus	0.000691	0.00349	CcSEcCtD
Haloperidol—Body temperature increased—Esomeprazole—Barrett's esophagus	0.000688	0.00347	CcSEcCtD
Haloperidol—Body temperature increased—Omeprazole—Barrett's esophagus	0.000688	0.00347	CcSEcCtD
Haloperidol—Hypersensitivity—Omeprazole—Barrett's esophagus	0.000641	0.00323	CcSEcCtD
Haloperidol—Hypersensitivity—Esomeprazole—Barrett's esophagus	0.000641	0.00323	CcSEcCtD
Haloperidol—Pruritus—Omeprazole—Barrett's esophagus	0.000616	0.0031	CcSEcCtD
Haloperidol—Pruritus—Esomeprazole—Barrett's esophagus	0.000616	0.0031	CcSEcCtD
Haloperidol—Diarrhoea—Esomeprazole—Barrett's esophagus	0.000595	0.003	CcSEcCtD
Haloperidol—Diarrhoea—Omeprazole—Barrett's esophagus	0.000595	0.003	CcSEcCtD
Haloperidol—Dizziness—Esomeprazole—Barrett's esophagus	0.000575	0.0029	CcSEcCtD
Haloperidol—Dizziness—Omeprazole—Barrett's esophagus	0.000575	0.0029	CcSEcCtD
Haloperidol—UGT1A9—digestive system—Barrett's esophagus	0.000558	0.107	CbGeAlD
Haloperidol—Vomiting—Omeprazole—Barrett's esophagus	0.000553	0.00279	CcSEcCtD
Haloperidol—Vomiting—Esomeprazole—Barrett's esophagus	0.000553	0.00279	CcSEcCtD
Haloperidol—Rash—Esomeprazole—Barrett's esophagus	0.000549	0.00277	CcSEcCtD
Haloperidol—Rash—Omeprazole—Barrett's esophagus	0.000549	0.00277	CcSEcCtD
Haloperidol—Dermatitis—Omeprazole—Barrett's esophagus	0.000548	0.00276	CcSEcCtD
Haloperidol—Dermatitis—Esomeprazole—Barrett's esophagus	0.000548	0.00276	CcSEcCtD
Haloperidol—Headache—Esomeprazole—Barrett's esophagus	0.000545	0.00275	CcSEcCtD
Haloperidol—Headache—Omeprazole—Barrett's esophagus	0.000545	0.00275	CcSEcCtD
Haloperidol—Nausea—Esomeprazole—Barrett's esophagus	0.000517	0.00261	CcSEcCtD
Haloperidol—Nausea—Omeprazole—Barrett's esophagus	0.000517	0.00261	CcSEcCtD
Haloperidol—H1F0—smooth muscle tissue—Barrett's esophagus	0.000436	0.0837	CbGeAlD
Haloperidol—CBR1—digestive system—Barrett's esophagus	0.00042	0.0806	CbGeAlD
Haloperidol—H1F0—digestive system—Barrett's esophagus	0.000344	0.0661	CbGeAlD
Haloperidol—SIGMAR1—smooth muscle tissue—Barrett's esophagus	0.000315	0.0604	CbGeAlD
Haloperidol—HTR2B—smooth muscle tissue—Barrett's esophagus	0.000314	0.0603	CbGeAlD
Haloperidol—HTR2B—digestive system—Barrett's esophagus	0.000248	0.0476	CbGeAlD
Haloperidol—CYP1A1—epithelium—Barrett's esophagus	0.00022	0.0422	CbGeAlD
Haloperidol—HRH1—epithelium—Barrett's esophagus	0.000208	0.04	CbGeAlD
Haloperidol—CYP2C19—digestive system—Barrett's esophagus	0.000207	0.0398	CbGeAlD
Haloperidol—HRH1—smooth muscle tissue—Barrett's esophagus	0.000201	0.0385	CbGeAlD
Haloperidol—HTR2A—epithelium—Barrett's esophagus	0.000174	0.0334	CbGeAlD
Haloperidol—CYP1A2—digestive system—Barrett's esophagus	0.000169	0.0325	CbGeAlD
Haloperidol—HTR2A—smooth muscle tissue—Barrett's esophagus	0.000168	0.0322	CbGeAlD
Haloperidol—CYP1A1—digestive system—Barrett's esophagus	0.000167	0.0321	CbGeAlD
Haloperidol—CYP3A5—digestive system—Barrett's esophagus	0.000163	0.0314	CbGeAlD
Haloperidol—CYP2C9—digestive system—Barrett's esophagus	0.000161	0.0309	CbGeAlD
Haloperidol—HRH1—digestive system—Barrett's esophagus	0.000159	0.0304	CbGeAlD
Haloperidol—DRD1—Class A/1 (Rhodopsin-like receptors)—SST—Barrett's esophagus	0.000149	0.00203	CbGpPWpGaD
Haloperidol—DRD3—Class A/1 (Rhodopsin-like receptors)—SST—Barrett's esophagus	0.000147	0.002	CbGpPWpGaD
Haloperidol—DRD2—G alpha (i) signalling events—SST—Barrett's esophagus	0.000141	0.00193	CbGpPWpGaD
Haloperidol—H1F0—Cellular Senescence—TP53—Barrett's esophagus	0.00014	0.0019	CbGpPWpGaD
Haloperidol—CYP1A2—Biological oxidations—CYP26A1—Barrett's esophagus	0.000139	0.0019	CbGpPWpGaD
Haloperidol—KCNH2—SIDS Susceptibility Pathways—CXCL8—Barrett's esophagus	0.000139	0.00189	CbGpPWpGaD
Haloperidol—CYP1A2—Metapathway biotransformation—CYP26A1—Barrett's esophagus	0.000137	0.00187	CbGpPWpGaD
Haloperidol—HTR2A—digestive system—Barrett's esophagus	0.000132	0.0254	CbGeAlD
Haloperidol—HTR1D—GPCR ligand binding—SST—Barrett's esophagus	0.000131	0.00178	CbGpPWpGaD
Haloperidol—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—Barrett's esophagus	0.000129	0.00176	CbGpPWpGaD
Haloperidol—HTR1B—GPCR ligand binding—SST—Barrett's esophagus	0.000128	0.00174	CbGpPWpGaD
Haloperidol—EBP—Metabolism of lipids and lipoproteins—PTGS2—Barrett's esophagus	0.000127	0.00174	CbGpPWpGaD
Haloperidol—DRD4—GPCR ligand binding—SST—Barrett's esophagus	0.000126	0.00172	CbGpPWpGaD
Haloperidol—CBR1—Metabolism of lipids and lipoproteins—PTGS2—Barrett's esophagus	0.000125	0.00171	CbGpPWpGaD
Haloperidol—CYP2C19—Arachidonic acid metabolism—PTGS2—Barrett's esophagus	0.000124	0.00169	CbGpPWpGaD
Haloperidol—CYP3A4—digestive system—Barrett's esophagus	0.000123	0.0235	CbGeAlD
Haloperidol—CYP2D6—digestive system—Barrett's esophagus	0.000121	0.0232	CbGeAlD
Haloperidol—UGT1A9—Fatty acid, triacylglycerol, and ketone body metabolism—PPARG—Barrett's esophagus	0.00012	0.00164	CbGpPWpGaD
Haloperidol—DRD4—Circadian rythm related genes—PPARG—Barrett's esophagus	0.00012	0.00164	CbGpPWpGaD
Haloperidol—HTR2B—GPCR ligand binding—SST—Barrett's esophagus	0.00012	0.00164	CbGpPWpGaD
Haloperidol—ABCB1—epithelium—Barrett's esophagus	0.000114	0.0219	CbGeAlD
Haloperidol—DRD1—GPCR ligand binding—SST—Barrett's esophagus	0.000113	0.00154	CbGpPWpGaD
Haloperidol—CYP2C9—Arachidonic acid metabolism—PTGS2—Barrett's esophagus	0.000113	0.00154	CbGpPWpGaD
Haloperidol—DRD2—Class A/1 (Rhodopsin-like receptors)—SST—Barrett's esophagus	0.000112	0.00153	CbGpPWpGaD
Haloperidol—DRD3—GPCR ligand binding—SST—Barrett's esophagus	0.000112	0.00152	CbGpPWpGaD
Haloperidol—HTR2A—Class A/1 (Rhodopsin-like receptors)—SST—Barrett's esophagus	0.00011	0.00151	CbGpPWpGaD
Haloperidol—CYP1A1—Metabolism of lipids and lipoproteins—PTGES—Barrett's esophagus	0.00011	0.00151	CbGpPWpGaD
Haloperidol—HRH1—Class A/1 (Rhodopsin-like receptors)—SST—Barrett's esophagus	0.00011	0.0015	CbGpPWpGaD
Haloperidol—DRD1—Circadian rythm related genes—PPARG—Barrett's esophagus	0.000108	0.00148	CbGpPWpGaD
Haloperidol—HTR1D—GPCR downstream signaling—GAST—Barrett's esophagus	0.000108	0.00147	CbGpPWpGaD
Haloperidol—CYP3A4—Biological oxidations—CYP26A1—Barrett's esophagus	0.000107	0.00146	CbGpPWpGaD
Haloperidol—DRD3—Circadian rythm related genes—PPARG—Barrett's esophagus	0.000107	0.00146	CbGpPWpGaD
Haloperidol—CYP1A2—Aryl Hydrocarbon Receptor—RELA—Barrett's esophagus	0.000106	0.00145	CbGpPWpGaD
Haloperidol—CYP3A4—Metapathway biotransformation—CYP26A1—Barrett's esophagus	0.000106	0.00144	CbGpPWpGaD
Haloperidol—H1F0—Cellular responses to stress—TP53—Barrett's esophagus	0.000105	0.00144	CbGpPWpGaD
Haloperidol—HTR1B—GPCR downstream signaling—GAST—Barrett's esophagus	0.000105	0.00144	CbGpPWpGaD
Haloperidol—DRD4—GPCR downstream signaling—GAST—Barrett's esophagus	0.000104	0.00141	CbGpPWpGaD
Haloperidol—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—Barrett's esophagus	0.000103	0.00141	CbGpPWpGaD
Haloperidol—CYP1A1—PPARA activates gene expression—PPARG—Barrett's esophagus	0.000103	0.0014	CbGpPWpGaD
Haloperidol—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—PPARG—Barrett's esophagus	0.0001	0.00137	CbGpPWpGaD
Haloperidol—HTR2B—GPCR downstream signaling—GAST—Barrett's esophagus	9.9e-05	0.00135	CbGpPWpGaD
Haloperidol—HTR1D—Signaling by GPCR—GAST—Barrett's esophagus	9.77e-05	0.00133	CbGpPWpGaD
Haloperidol—CYP1A2—Arachidonic acid metabolism—PTGS2—Barrett's esophagus	9.66e-05	0.00132	CbGpPWpGaD
Haloperidol—HTR1B—Signaling by GPCR—GAST—Barrett's esophagus	9.57e-05	0.00131	CbGpPWpGaD
Haloperidol—DRD4—Signaling by GPCR—GAST—Barrett's esophagus	9.42e-05	0.00128	CbGpPWpGaD
Haloperidol—DRD1—GPCR downstream signaling—GAST—Barrett's esophagus	9.33e-05	0.00127	CbGpPWpGaD
Haloperidol—DRD3—GPCR downstream signaling—GAST—Barrett's esophagus	9.21e-05	0.00126	CbGpPWpGaD
Haloperidol—CYP2C19—Metabolism of lipids and lipoproteins—PTGES—Barrett's esophagus	9.04e-05	0.00123	CbGpPWpGaD
Haloperidol—HTR2B—Signaling by GPCR—GAST—Barrett's esophagus	8.99e-05	0.00123	CbGpPWpGaD
Haloperidol—ABCB1—digestive system—Barrett's esophagus	8.68e-05	0.0167	CbGeAlD
Haloperidol—UGT1A9—Metabolism—PTGES—Barrett's esophagus	8.56e-05	0.00117	CbGpPWpGaD
Haloperidol—DRD2—GPCR ligand binding—SST—Barrett's esophagus	8.55e-05	0.00117	CbGpPWpGaD
Haloperidol—DRD1—Signaling by GPCR—GAST—Barrett's esophagus	8.48e-05	0.00116	CbGpPWpGaD
Haloperidol—GRIN2B—Developmental Biology—PPARG—Barrett's esophagus	8.45e-05	0.00115	CbGpPWpGaD
Haloperidol—HTR2A—GPCR ligand binding—SST—Barrett's esophagus	8.41e-05	0.00115	CbGpPWpGaD
Haloperidol—HTR1D—G alpha (i) signalling events—CXCL8—Barrett's esophagus	8.4e-05	0.00115	CbGpPWpGaD
Haloperidol—HRH1—GPCR ligand binding—SST—Barrett's esophagus	8.39e-05	0.00114	CbGpPWpGaD
Haloperidol—DRD3—Signaling by GPCR—GAST—Barrett's esophagus	8.36e-05	0.00114	CbGpPWpGaD
Haloperidol—CYP2C9—Metabolism of lipids and lipoproteins—PTGES—Barrett's esophagus	8.24e-05	0.00112	CbGpPWpGaD
Haloperidol—HTR1B—G alpha (i) signalling events—CXCL8—Barrett's esophagus	8.22e-05	0.00112	CbGpPWpGaD
Haloperidol—DRD2—Circadian rythm related genes—PPARG—Barrett's esophagus	8.17e-05	0.00111	CbGpPWpGaD
Haloperidol—ABCB1—Allograft Rejection—CXCL8—Barrett's esophagus	8.14e-05	0.00111	CbGpPWpGaD
Haloperidol—DRD4—G alpha (i) signalling events—CXCL8—Barrett's esophagus	8.09e-05	0.0011	CbGpPWpGaD
Haloperidol—HTR2A—SIDS Susceptibility Pathways—CXCL8—Barrett's esophagus	7.51e-05	0.00102	CbGpPWpGaD
Haloperidol—ABCB1—Transmembrane transport of small molecules—ATP4A—Barrett's esophagus	7.47e-05	0.00102	CbGpPWpGaD
Haloperidol—HTR1D—GPCR downstream signaling—SST—Barrett's esophagus	7.38e-05	0.00101	CbGpPWpGaD
Haloperidol—HTR1B—GPCR downstream signaling—SST—Barrett's esophagus	7.22e-05	0.000985	CbGpPWpGaD
Haloperidol—EBP—Metabolism—PPARG—Barrett's esophagus	7.22e-05	0.000985	CbGpPWpGaD
Haloperidol—CYP3A7—Metabolism—PTGES—Barrett's esophagus	7.2e-05	0.000982	CbGpPWpGaD
Haloperidol—DRD3—G alpha (i) signalling events—CXCL8—Barrett's esophagus	7.19e-05	0.000981	CbGpPWpGaD
Haloperidol—DRD4—GPCR downstream signaling—SST—Barrett's esophagus	7.11e-05	0.000969	CbGpPWpGaD
Haloperidol—CBR1—Metabolism—PPARG—Barrett's esophagus	7.1e-05	0.000969	CbGpPWpGaD
Haloperidol—DRD2—GPCR downstream signaling—GAST—Barrett's esophagus	7.05e-05	0.000961	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism of lipids and lipoproteins—PTGES—Barrett's esophagus	7.04e-05	0.000961	CbGpPWpGaD
Haloperidol—HTR2A—GPCR downstream signaling—GAST—Barrett's esophagus	6.93e-05	0.000946	CbGpPWpGaD
Haloperidol—HRH1—GPCR downstream signaling—GAST—Barrett's esophagus	6.92e-05	0.000944	CbGpPWpGaD
Haloperidol—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—PPARG—Barrett's esophagus	6.92e-05	0.000943	CbGpPWpGaD
Haloperidol—GRIN2B—Developmental Biology—RELA—Barrett's esophagus	6.84e-05	0.000934	CbGpPWpGaD
Haloperidol—HTR2B—GPCR downstream signaling—SST—Barrett's esophagus	6.78e-05	0.000925	CbGpPWpGaD
Haloperidol—HTR1D—Signaling by GPCR—SST—Barrett's esophagus	6.7e-05	0.000914	CbGpPWpGaD
Haloperidol—HTR1D—Class A/1 (Rhodopsin-like receptors)—CXCL8—Barrett's esophagus	6.68e-05	0.000911	CbGpPWpGaD
Haloperidol—HTR1B—Signaling by GPCR—SST—Barrett's esophagus	6.56e-05	0.000895	CbGpPWpGaD
Haloperidol—HTR1B—Class A/1 (Rhodopsin-like receptors)—CXCL8—Barrett's esophagus	6.54e-05	0.000892	CbGpPWpGaD
Haloperidol—UGT1A9—Metabolism—CYP26A1—Barrett's esophagus	6.49e-05	0.000885	CbGpPWpGaD
Haloperidol—DRD4—Signaling by GPCR—SST—Barrett's esophagus	6.45e-05	0.00088	CbGpPWpGaD
Haloperidol—DRD4—Class A/1 (Rhodopsin-like receptors)—CXCL8—Barrett's esophagus	6.43e-05	0.000878	CbGpPWpGaD
Haloperidol—DRD2—Signaling by GPCR—GAST—Barrett's esophagus	6.4e-05	0.000873	CbGpPWpGaD
Haloperidol—DRD1—GPCR downstream signaling—SST—Barrett's esophagus	6.4e-05	0.000873	CbGpPWpGaD
Haloperidol—DRD3—GPCR downstream signaling—SST—Barrett's esophagus	6.31e-05	0.000861	CbGpPWpGaD
Haloperidol—HTR2A—Signaling by GPCR—GAST—Barrett's esophagus	6.3e-05	0.000859	CbGpPWpGaD
Haloperidol—HRH1—Signaling by GPCR—GAST—Barrett's esophagus	6.28e-05	0.000857	CbGpPWpGaD
Haloperidol—HTR2B—Signaling by GPCR—SST—Barrett's esophagus	6.16e-05	0.00084	CbGpPWpGaD
Haloperidol—HTR2B—Class A/1 (Rhodopsin-like receptors)—CXCL8—Barrett's esophagus	6.14e-05	0.000838	CbGpPWpGaD
Haloperidol—DRD1—Signaling by GPCR—SST—Barrett's esophagus	5.81e-05	0.000793	CbGpPWpGaD
Haloperidol—DRD1—Class A/1 (Rhodopsin-like receptors)—CXCL8—Barrett's esophagus	5.79e-05	0.00079	CbGpPWpGaD
Haloperidol—HTR1D—Signaling Pathways—GAST—Barrett's esophagus	5.77e-05	0.000788	CbGpPWpGaD
Haloperidol—DRD3—Signaling by GPCR—SST—Barrett's esophagus	5.73e-05	0.000782	CbGpPWpGaD
Haloperidol—DRD3—Class A/1 (Rhodopsin-like receptors)—CXCL8—Barrett's esophagus	5.71e-05	0.00078	CbGpPWpGaD
Haloperidol—EBP—Metabolism—PTGS2—Barrett's esophagus	5.68e-05	0.000774	CbGpPWpGaD
Haloperidol—HTR1B—Signaling Pathways—GAST—Barrett's esophagus	5.65e-05	0.000771	CbGpPWpGaD
Haloperidol—DRD4—Circadian rythm related genes—TP53—Barrett's esophagus	5.63e-05	0.000768	CbGpPWpGaD
Haloperidol—CBR1—Metabolism—PTGS2—Barrett's esophagus	5.59e-05	0.000762	CbGpPWpGaD
Haloperidol—DRD4—Signaling Pathways—GAST—Barrett's esophagus	5.56e-05	0.000759	CbGpPWpGaD
Haloperidol—DRD2—G alpha (i) signalling events—CXCL8—Barrett's esophagus	5.5e-05	0.00075	CbGpPWpGaD
Haloperidol—ABCB1—Integrated Pancreatic Cancer Pathway—APC—Barrett's esophagus	5.46e-05	0.000745	CbGpPWpGaD
Haloperidol—CYP3A7—Metabolism—CYP26A1—Barrett's esophagus	5.46e-05	0.000744	CbGpPWpGaD
Haloperidol—HTR2B—Signaling Pathways—GAST—Barrett's esophagus	5.31e-05	0.000724	CbGpPWpGaD
Haloperidol—CYP3A5—Metabolism—PTGES—Barrett's esophagus	5.21e-05	0.00071	CbGpPWpGaD
Haloperidol—HTR1D—GPCR ligand binding—CXCL8—Barrett's esophagus	5.08e-05	0.000694	CbGpPWpGaD
Haloperidol—DRD1—Circadian rythm related genes—TP53—Barrett's esophagus	5.07e-05	0.000691	CbGpPWpGaD
Haloperidol—DRD1—Signaling Pathways—GAST—Barrett's esophagus	5.01e-05	0.000683	CbGpPWpGaD
Haloperidol—DRD3—Circadian rythm related genes—TP53—Barrett's esophagus	5e-05	0.000682	CbGpPWpGaD
Haloperidol—HTR1B—GPCR ligand binding—CXCL8—Barrett's esophagus	4.98e-05	0.000679	CbGpPWpGaD
Haloperidol—DRD3—Signaling Pathways—GAST—Barrett's esophagus	4.94e-05	0.000674	CbGpPWpGaD
Haloperidol—CYP1A1—Metabolism—PTGES—Barrett's esophagus	4.92e-05	0.000671	CbGpPWpGaD
Haloperidol—DRD4—GPCR ligand binding—CXCL8—Barrett's esophagus	4.9e-05	0.000668	CbGpPWpGaD
Haloperidol—DRD2—GPCR downstream signaling—SST—Barrett's esophagus	4.83e-05	0.000659	CbGpPWpGaD
Haloperidol—UGT1A9—Metabolism of lipids and lipoproteins—PPARG—Barrett's esophagus	4.79e-05	0.000654	CbGpPWpGaD
Haloperidol—HTR2A—GPCR downstream signaling—SST—Barrett's esophagus	4.75e-05	0.000648	CbGpPWpGaD
Haloperidol—HRH1—GPCR downstream signaling—SST—Barrett's esophagus	4.74e-05	0.000647	CbGpPWpGaD
Haloperidol—UGT1A9—Metabolism—SLC9A1—Barrett's esophagus	4.68e-05	0.000638	CbGpPWpGaD
Haloperidol—HTR2B—GPCR ligand binding—CXCL8—Barrett's esophagus	4.68e-05	0.000638	CbGpPWpGaD
Haloperidol—ABCB1—Transmembrane transport of small molecules—SLC9A1—Barrett's esophagus	4.58e-05	0.000625	CbGpPWpGaD
Haloperidol—DRD1—GPCR ligand binding—CXCL8—Barrett's esophagus	4.41e-05	0.000602	CbGpPWpGaD
Haloperidol—DRD2—Signaling by GPCR—SST—Barrett's esophagus	4.39e-05	0.000598	CbGpPWpGaD
Haloperidol—DRD2—Class A/1 (Rhodopsin-like receptors)—CXCL8—Barrett's esophagus	4.37e-05	0.000597	CbGpPWpGaD
Haloperidol—DRD3—GPCR ligand binding—CXCL8—Barrett's esophagus	4.35e-05	0.000594	CbGpPWpGaD
Haloperidol—HTR2A—Signaling by GPCR—SST—Barrett's esophagus	4.32e-05	0.000589	CbGpPWpGaD
Haloperidol—HRH1—Signaling by GPCR—SST—Barrett's esophagus	4.31e-05	0.000588	CbGpPWpGaD
Haloperidol—HTR2A—Class A/1 (Rhodopsin-like receptors)—CXCL8—Barrett's esophagus	4.3e-05	0.000587	CbGpPWpGaD
Haloperidol—HRH1—Class A/1 (Rhodopsin-like receptors)—CXCL8—Barrett's esophagus	4.29e-05	0.000586	CbGpPWpGaD
Haloperidol—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—Barrett's esophagus	4.14e-05	0.000565	CbGpPWpGaD
Haloperidol—CYP2C19—Metabolism—PTGES—Barrett's esophagus	4.02e-05	0.000549	CbGpPWpGaD
Haloperidol—HTR1D—Signaling Pathways—SST—Barrett's esophagus	3.96e-05	0.00054	CbGpPWpGaD
Haloperidol—CYP3A5—Metabolism—CYP26A1—Barrett's esophagus	3.95e-05	0.000538	CbGpPWpGaD
Haloperidol—CYP3A7—Metabolism—SLC9A1—Barrett's esophagus	3.93e-05	0.000537	CbGpPWpGaD
Haloperidol—ABCB1—Metabolism—PTGES—Barrett's esophagus	3.93e-05	0.000536	CbGpPWpGaD
Haloperidol—HTR1B—Signaling Pathways—SST—Barrett's esophagus	3.87e-05	0.000529	CbGpPWpGaD
Haloperidol—DRD2—Circadian rythm related genes—TP53—Barrett's esophagus	3.82e-05	0.000522	CbGpPWpGaD
Haloperidol—DRD4—Signaling Pathways—SST—Barrett's esophagus	3.81e-05	0.00052	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—GAST—Barrett's esophagus	3.78e-05	0.000516	CbGpPWpGaD
Haloperidol—UGT1A9—Metabolism of lipids and lipoproteins—PTGS2—Barrett's esophagus	3.77e-05	0.000515	CbGpPWpGaD
Haloperidol—CYP1A1—Metabolism—CYP26A1—Barrett's esophagus	3.73e-05	0.000508	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—GAST—Barrett's esophagus	3.72e-05	0.000507	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—GAST—Barrett's esophagus	3.71e-05	0.000506	CbGpPWpGaD
Haloperidol—CYP2D6—Metabolism—PTGES—Barrett's esophagus	3.7e-05	0.000505	CbGpPWpGaD
Haloperidol—CYP2C9—Metabolism—PTGES—Barrett's esophagus	3.67e-05	0.000501	CbGpPWpGaD
Haloperidol—HTR2B—Signaling Pathways—SST—Barrett's esophagus	3.64e-05	0.000496	CbGpPWpGaD
Haloperidol—DRD1—Signaling Pathways—SST—Barrett's esophagus	3.43e-05	0.000468	CbGpPWpGaD
Haloperidol—DRD3—Signaling Pathways—SST—Barrett's esophagus	3.39e-05	0.000462	CbGpPWpGaD
Haloperidol—DRD2—GPCR ligand binding—CXCL8—Barrett's esophagus	3.33e-05	0.000454	CbGpPWpGaD
Haloperidol—HTR2A—GPCR ligand binding—CXCL8—Barrett's esophagus	3.28e-05	0.000447	CbGpPWpGaD
Haloperidol—HRH1—GPCR ligand binding—CXCL8—Barrett's esophagus	3.27e-05	0.000446	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism—PTGES—Barrett's esophagus	3.14e-05	0.000428	CbGpPWpGaD
Haloperidol—CYP2C19—Metabolism—CYP26A1—Barrett's esophagus	3.05e-05	0.000416	CbGpPWpGaD
Haloperidol—ABCB1—Metabolism—CYP26A1—Barrett's esophagus	2.98e-05	0.000406	CbGpPWpGaD
Haloperidol—HTR1D—GPCR downstream signaling—CXCL8—Barrett's esophagus	2.87e-05	0.000392	CbGpPWpGaD
Haloperidol—CYP3A5—Metabolism—SLC9A1—Barrett's esophagus	2.84e-05	0.000388	CbGpPWpGaD
Haloperidol—HTR1B—GPCR downstream signaling—CXCL8—Barrett's esophagus	2.81e-05	0.000384	CbGpPWpGaD
Haloperidol—CYP2D6—Metabolism—CYP26A1—Barrett's esophagus	2.81e-05	0.000383	CbGpPWpGaD
Haloperidol—CYP2C9—Metabolism—CYP26A1—Barrett's esophagus	2.78e-05	0.000379	CbGpPWpGaD
Haloperidol—DRD4—GPCR downstream signaling—CXCL8—Barrett's esophagus	2.77e-05	0.000378	CbGpPWpGaD
Haloperidol—CYP1A1—Metabolism of lipids and lipoproteins—PPARG—Barrett's esophagus	2.75e-05	0.000376	CbGpPWpGaD
Haloperidol—CYP1A1—Metabolism—SLC9A1—Barrett's esophagus	2.69e-05	0.000367	CbGpPWpGaD
Haloperidol—HTR2B—GPCR downstream signaling—CXCL8—Barrett's esophagus	2.64e-05	0.000361	CbGpPWpGaD
Haloperidol—HTR1D—Signaling by GPCR—CXCL8—Barrett's esophagus	2.61e-05	0.000356	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—SST—Barrett's esophagus	2.59e-05	0.000353	CbGpPWpGaD
Haloperidol—HTR1B—Signaling by GPCR—CXCL8—Barrett's esophagus	2.56e-05	0.000349	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—SST—Barrett's esophagus	2.55e-05	0.000348	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—SST—Barrett's esophagus	2.54e-05	0.000347	CbGpPWpGaD
Haloperidol—DRD4—Signaling by GPCR—CXCL8—Barrett's esophagus	2.51e-05	0.000343	CbGpPWpGaD
Haloperidol—DRD1—GPCR downstream signaling—CXCL8—Barrett's esophagus	2.49e-05	0.00034	CbGpPWpGaD
Haloperidol—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—Barrett's esophagus	2.47e-05	0.000336	CbGpPWpGaD
Haloperidol—DRD3—GPCR downstream signaling—CXCL8—Barrett's esophagus	2.46e-05	0.000335	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—PTGES—Barrett's esophagus	2.42e-05	0.00033	CbGpPWpGaD
Haloperidol—HTR2B—Signaling by GPCR—CXCL8—Barrett's esophagus	2.4e-05	0.000327	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism—CYP26A1—Barrett's esophagus	2.38e-05	0.000324	CbGpPWpGaD
Haloperidol—DRD1—Signaling by GPCR—CXCL8—Barrett's esophagus	2.26e-05	0.000309	CbGpPWpGaD
Haloperidol—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—Barrett's esophagus	2.25e-05	0.000307	CbGpPWpGaD
Haloperidol—DRD3—Signaling by GPCR—CXCL8—Barrett's esophagus	2.23e-05	0.000305	CbGpPWpGaD
Haloperidol—CYP2C19—Metabolism—SLC9A1—Barrett's esophagus	2.2e-05	0.0003	CbGpPWpGaD
Haloperidol—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—Barrett's esophagus	2.17e-05	0.000296	CbGpPWpGaD
Haloperidol—ABCB1—Metabolism—SLC9A1—Barrett's esophagus	2.15e-05	0.000293	CbGpPWpGaD
Haloperidol—UGT1A9—Metabolism—PPARG—Barrett's esophagus	2.14e-05	0.000291	CbGpPWpGaD
Haloperidol—HTR1D—Signaling Pathways—APC—Barrett's esophagus	2.09e-05	0.000286	CbGpPWpGaD
Haloperidol—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—Barrett's esophagus	2.05e-05	0.00028	CbGpPWpGaD
Haloperidol—HTR1B—Signaling Pathways—APC—Barrett's esophagus	2.05e-05	0.00028	CbGpPWpGaD
Haloperidol—CYP2D6—Metabolism—SLC9A1—Barrett's esophagus	2.02e-05	0.000276	CbGpPWpGaD
Haloperidol—DRD4—Signaling Pathways—APC—Barrett's esophagus	2.02e-05	0.000275	CbGpPWpGaD
Haloperidol—CYP2C9—Metabolism—SLC9A1—Barrett's esophagus	2e-05	0.000273	CbGpPWpGaD
Haloperidol—HTR2B—Signaling Pathways—APC—Barrett's esophagus	1.93e-05	0.000263	CbGpPWpGaD
Haloperidol—DRD2—GPCR downstream signaling—CXCL8—Barrett's esophagus	1.88e-05	0.000257	CbGpPWpGaD
Haloperidol—HTR2A—GPCR downstream signaling—CXCL8—Barrett's esophagus	1.85e-05	0.000253	CbGpPWpGaD
Haloperidol—HRH1—GPCR downstream signaling—CXCL8—Barrett's esophagus	1.85e-05	0.000252	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—CYP26A1—Barrett's esophagus	1.83e-05	0.00025	CbGpPWpGaD
Haloperidol—DRD1—Signaling Pathways—APC—Barrett's esophagus	1.82e-05	0.000248	CbGpPWpGaD
Haloperidol—CYP3A7—Metabolism—PPARG—Barrett's esophagus	1.8e-05	0.000245	CbGpPWpGaD
Haloperidol—DRD3—Signaling Pathways—APC—Barrett's esophagus	1.79e-05	0.000244	CbGpPWpGaD
Haloperidol—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—Barrett's esophagus	1.77e-05	0.000242	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—Barrett's esophagus	1.76e-05	0.00024	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism—SLC9A1—Barrett's esophagus	1.71e-05	0.000234	CbGpPWpGaD
Haloperidol—DRD2—Signaling by GPCR—CXCL8—Barrett's esophagus	1.71e-05	0.000233	CbGpPWpGaD
Haloperidol—HTR2A—Signaling by GPCR—CXCL8—Barrett's esophagus	1.68e-05	0.000229	CbGpPWpGaD
Haloperidol—UGT1A9—Metabolism—PTGS2—Barrett's esophagus	1.68e-05	0.000229	CbGpPWpGaD
Haloperidol—HRH1—Signaling by GPCR—CXCL8—Barrett's esophagus	1.68e-05	0.000229	CbGpPWpGaD
Haloperidol—HTR1D—Signaling Pathways—RELA—Barrett's esophagus	1.64e-05	0.000223	CbGpPWpGaD
Haloperidol—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—Barrett's esophagus	1.62e-05	0.000221	CbGpPWpGaD
Haloperidol—HTR1B—Signaling Pathways—RELA—Barrett's esophagus	1.6e-05	0.000218	CbGpPWpGaD
Haloperidol—DRD4—Signaling Pathways—RELA—Barrett's esophagus	1.58e-05	0.000215	CbGpPWpGaD
Haloperidol—HTR1D—Signaling Pathways—CXCL8—Barrett's esophagus	1.54e-05	0.00021	CbGpPWpGaD
Haloperidol—HTR1B—Signaling Pathways—CXCL8—Barrett's esophagus	1.51e-05	0.000206	CbGpPWpGaD
Haloperidol—HTR2B—Signaling Pathways—RELA—Barrett's esophagus	1.5e-05	0.000205	CbGpPWpGaD
Haloperidol—DRD4—Signaling Pathways—CXCL8—Barrett's esophagus	1.49e-05	0.000203	CbGpPWpGaD
Haloperidol—DRD1—Signaling Pathways—RELA—Barrett's esophagus	1.42e-05	0.000194	CbGpPWpGaD
Haloperidol—HTR2B—Signaling Pathways—CXCL8—Barrett's esophagus	1.42e-05	0.000193	CbGpPWpGaD
Haloperidol—CYP3A7—Metabolism—PTGS2—Barrett's esophagus	1.41e-05	0.000193	CbGpPWpGaD
Haloperidol—DRD3—Signaling Pathways—RELA—Barrett's esophagus	1.4e-05	0.000191	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—Barrett's esophagus	1.38e-05	0.000188	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—APC—Barrett's esophagus	1.37e-05	0.000187	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—APC—Barrett's esophagus	1.35e-05	0.000184	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—APC—Barrett's esophagus	1.35e-05	0.000184	CbGpPWpGaD
Haloperidol—DRD1—Signaling Pathways—CXCL8—Barrett's esophagus	1.34e-05	0.000182	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—SLC9A1—Barrett's esophagus	1.32e-05	0.00018	CbGpPWpGaD
Haloperidol—DRD3—Signaling Pathways—CXCL8—Barrett's esophagus	1.32e-05	0.00018	CbGpPWpGaD
Haloperidol—CYP3A5—Metabolism—PPARG—Barrett's esophagus	1.3e-05	0.000177	CbGpPWpGaD
Haloperidol—CYP1A1—Metabolism—PPARG—Barrett's esophagus	1.23e-05	0.000167	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—RELA—Barrett's esophagus	1.07e-05	0.000146	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—RELA—Barrett's esophagus	1.05e-05	0.000144	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—RELA—Barrett's esophagus	1.05e-05	0.000143	CbGpPWpGaD
Haloperidol—CYP3A5—Metabolism—PTGS2—Barrett's esophagus	1.02e-05	0.000139	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—CXCL8—Barrett's esophagus	1.01e-05	0.000138	CbGpPWpGaD
Haloperidol—CYP2C19—Metabolism—PPARG—Barrett's esophagus	1e-05	0.000137	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—CXCL8—Barrett's esophagus	9.93e-06	0.000136	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—CXCL8—Barrett's esophagus	9.91e-06	0.000135	CbGpPWpGaD
Haloperidol—ABCB1—Metabolism—PPARG—Barrett's esophagus	9.8e-06	0.000134	CbGpPWpGaD
Haloperidol—CYP1A1—Metabolism—PTGS2—Barrett's esophagus	9.65e-06	0.000132	CbGpPWpGaD
Haloperidol—HTR1D—Signaling Pathways—TP53—Barrett's esophagus	9.46e-06	0.000129	CbGpPWpGaD
Haloperidol—HTR1B—Signaling Pathways—TP53—Barrett's esophagus	9.26e-06	0.000126	CbGpPWpGaD
Haloperidol—CYP2D6—Metabolism—PPARG—Barrett's esophagus	9.23e-06	0.000126	CbGpPWpGaD
Haloperidol—CYP2C9—Metabolism—PPARG—Barrett's esophagus	9.15e-06	0.000125	CbGpPWpGaD
Haloperidol—DRD4—Signaling Pathways—TP53—Barrett's esophagus	9.12e-06	0.000124	CbGpPWpGaD
Haloperidol—HTR2B—Signaling Pathways—TP53—Barrett's esophagus	8.7e-06	0.000119	CbGpPWpGaD
Haloperidol—DRD1—Signaling Pathways—TP53—Barrett's esophagus	8.21e-06	0.000112	CbGpPWpGaD
Haloperidol—DRD3—Signaling Pathways—TP53—Barrett's esophagus	8.1e-06	0.00011	CbGpPWpGaD
Haloperidol—CYP2C19—Metabolism—PTGS2—Barrett's esophagus	7.89e-06	0.000108	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism—PPARG—Barrett's esophagus	7.82e-06	0.000107	CbGpPWpGaD
Haloperidol—ABCB1—Metabolism—PTGS2—Barrett's esophagus	7.71e-06	0.000105	CbGpPWpGaD
Haloperidol—CYP2D6—Metabolism—PTGS2—Barrett's esophagus	7.26e-06	9.91e-05	CbGpPWpGaD
Haloperidol—CYP2C9—Metabolism—PTGS2—Barrett's esophagus	7.2e-06	9.82e-05	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—TP53—Barrett's esophagus	6.2e-06	8.45e-05	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism—PTGS2—Barrett's esophagus	6.15e-06	8.39e-05	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—TP53—Barrett's esophagus	6.1e-06	8.32e-05	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—TP53—Barrett's esophagus	6.08e-06	8.3e-05	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—PPARG—Barrett's esophagus	6.04e-06	8.23e-05	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—PTGS2—Barrett's esophagus	4.75e-06	6.48e-05	CbGpPWpGaD
